|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
230,290,000 |
Market
Cap: |
138.17(K) |
Last
Volume: |
11,847,187 |
Avg
Vol: |
11,814,847 |
52
Week Range: |
$0.0001 - $0.058 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Endo International is a holding company. Through its subsidiaries, Co. is engaged in specialty pharmaceuticals. Co.'s segments are: Branded Pharmaceuticals, which includes branded products to treat and manage conditions in the areas of urology, orthopedics, endocrinology and bariatrics, among others; Sterile Injectables, which consists of branded sterile injectable products; Generic Pharmaceuticals, which includes generic product families that treat and manage a range of medical conditions; and International Pharmaceuticals, which includes products serving therapeutic areas, including attention deficit hyperactivity disorder, pain, women's health, oncology and transplantation.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Loverro Frank J |
officerTitle |
|
2005-11-22 |
4 |
OE |
$2.42 |
$93,463 |
I/I |
33,423 |
15,997,661 |
|
- |
|
Loverro Frank J |
officerTitle |
|
2005-11-22 |
4 |
OE |
$2.42 |
$101,323 |
I/I |
36,234 |
17,343,762 |
|
- |
|
Endo Pharma Llc |
officerTitle |
|
2005-11-22 |
4 |
OE |
$2.42 |
$121,180 |
D/D |
43,335 |
20,742,445 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-21 |
4 |
OE |
$2.42 |
$62,411 |
I/I |
21,664 |
16,031,083 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-21 |
4 |
OE |
$2.42 |
$67,663 |
I/I |
23,487 |
17,379,996 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-21 |
4 |
OE |
$2.42 |
$80,918 |
D/D |
28,088 |
20,785,780 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-18 |
4 |
OE |
$2.42 |
$196,603 |
I/I |
76,826 |
16,052,746 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-18 |
4 |
OE |
$2.42 |
$213,144 |
I/I |
83,290 |
17,403,482 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-18 |
4 |
OE |
$2.42 |
$254,914 |
D/D |
99,612 |
20,813,868 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-17 |
4 |
OE |
$2.42 |
$250,012 |
I/I |
90,936 |
16,129,572 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-17 |
4 |
OE |
$2.42 |
$271,054 |
I/I |
98,590 |
17,486,772 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-17 |
4 |
OE |
$2.42 |
$324,168 |
D/D |
117,909 |
20,913,480 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-16 |
4 |
OE |
$2.42 |
$27,170 |
I/I |
11,047 |
16,220,510 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-16 |
4 |
OE |
$2.42 |
$29,453 |
I/I |
11,975 |
17,585,362 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-16 |
4 |
OE |
$2.42 |
$35,225 |
D/D |
14,322 |
21,031,389 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-11-15 |
4 |
OE |
$2.42 |
$116,621 |
I/I |
43,243 |
16,231,555 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-11-15 |
4 |
OE |
$2.42 |
$126,438 |
I/I |
46,883 |
17,597,337 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-15 |
4 |
OE |
$2.42 |
$151,212 |
D/D |
56,069 |
21,045,711 |
|
- |
|
Kelso Partners V L P |
10% Owner |
|
2005-11-15 |
4 |
OE |
$2.42 |
$116,621 |
I/I |
43,243 |
16,231,555 |
|
- |
|
Kelso Equity Partners V L P |
10% Owner |
|
2005-11-15 |
4 |
OE |
$2.42 |
$126,438 |
I/I |
46,883 |
17,597,337 |
|
- |
|
Kelso Investment Assoc V L P |
10% Owner |
|
2005-11-15 |
4 |
OE |
$2.42 |
$126,438 |
I/I |
46,883 |
17,597,337 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-14 |
4 |
OE |
$2.42 |
$61,852 |
I/I |
21,207 |
16,274,799 |
|
- |
|
Loverro Frank J |
10% Owner |
|
2005-11-14 |
4 |
OE |
$2.42 |
$67,061 |
I/I |
22,993 |
17,644,219 |
|
- |
|
Endo Pharma Llc |
10% Owner |
|
2005-11-14 |
4 |
OE |
$2.42 |
$80,201 |
D/D |
27,498 |
21,101,780 |
|
- |
|
Connors James J Ii |
10% Owner |
|
2005-11-11 |
4 |
OE |
$2.42 |
$116,448 |
I/I |
43,034 |
16,296,007 |
|
- |
|
825 Records found
|
|
Page 22 of 33 |
|
|